{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T10:31:46Z","timestamp":1794393106854,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.oooo.2014.06.002","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T17:16:22Z","timestamp":1402938982000},"page":"338-347","source":"Crossref","is-referenced-by-count":14,"title":["Large B-cell lymphoma of the base of the tongue and oral cavity: a practical approach to identifying prognostically important subtypes"],"prefix":"10.1016","volume":"118","author":[{"given":"Adepitan A.","family":"Owosho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Bilodeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvashi","family":"Surti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona E.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2014.06.002_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1067\/moe.2001.116062","article-title":"Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases","volume":"92","author":"Epstein","year":"2001","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2014.06.002_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijom.2004.08.009","article-title":"Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index","volume":"34","author":"van der Waal","year":"2005","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2014.06.002_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/hupa.2002.30721","article-title":"Lymphomas of the oral cavity: histology, immunologic type, and incidence of Epstein-Barr virus infection","volume":"33","author":"Solomides","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0964-1955(94)90063-9","article-title":"Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases","volume":"30 B","author":"Wolvius","year":"1994","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.oooo.2014.06.002_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tripleo.2004.03.028","article-title":"Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: A clinical study","volume":"99","author":"Kolokotronis","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2014.06.002_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tripleo.2007.02.019","article-title":"Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases","volume":"105","author":"Kemp","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2014.06.002_bib7","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.oooo.2014.06.002_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00019606-199203000-00037","article-title":"Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues","volume":"1","author":"Chang","year":"1992","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.humpath.2003.08.007","article-title":"T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma","volume":"34","author":"Cook","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib12","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-9896(199607)179:3<238::AID-PATH566>3.0.CO;2-W","article-title":"bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma","volume":"179","author":"Ott","year":"1996","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","article-title":"Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors","volume":"82","author":"Bosch","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.oooo.2014.06.002_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","article-title":"A\u00a0clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study","volume":"85","author":"Fisher","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/10428194.2010.540361","article-title":"Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus","volume":"52","author":"Vela-Chavez","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.oooo.2014.06.002_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/modpathol.2012.52","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation","volume":"25","author":"Montes-Moreno","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib18","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer\u2014a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A\u00a0revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2559.2003.01758.x","article-title":"Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance","volume":"43","author":"de Leval","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.oooo.2014.06.002_bib22","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2005-02-0542","article-title":"Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma","volume":"106","author":"Tagawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2559.1990.tb00709.x","article-title":"CD30 expression in non-Hodgkin's lymphoma","volume":"17","author":"Piris","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.oooo.2014.06.002_bib24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1056\/NEJM199407143310202","article-title":"Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma","volume":"331","author":"Offit","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2014.06.002_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10428199709068271","article-title":"Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms","volume":"27","author":"Ohno","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.oooo.2014.06.002_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","article-title":"Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas","volume":"317","author":"Weiss","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2014.06.002_bib28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198904203201605","article-title":"bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma","volume":"320","author":"Yunis","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oooo.2014.06.002_bib29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.oooo.2014.06.002_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3960\/jslrt.52.91","article-title":"Germinal center B-cell-like versus non-germinal center B-cell-like as important prognostic factor for localized nodal DLBCL","volume":"52","author":"Habara","year":"2012","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.oooo.2014.06.002_bib31","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","article-title":"Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy","volume":"109","author":"Nyman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2559.2007.02721.x","article-title":"Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients","volume":"51","author":"Amen","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.oooo.2014.06.002_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oooo.2014.06.002_bib34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.anndiagpath.2012.11.001","article-title":"Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina","volume":"17","author":"Burgesser","year":"2013","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib35","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/01.pas.0000180442.87022.08","article-title":"Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior","volume":"29","author":"McClure","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3960\/jslrt.51.37","article-title":"A\u00a0highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma","volume":"51","author":"Kurita","year":"2011","journal-title":"J\u00a0Clin Exp Hematop"},{"key":"10.1016\/j.oooo.2014.06.002_bib37","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3324\/haematol.2008.005355","article-title":"Clinicopathological features of lymphoma\/leukemia patients carrying both BCL2 and MYC translocations","volume":"94","author":"Tomita","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.oooo.2014.06.002_bib38","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/PAS.0b013e318244e2ba","article-title":"High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma","volume":"36","author":"Green","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.oooo.2014.06.002_bib39","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1182\/blood-2012-05-428466","article-title":"Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab\/R-CHOP","volume":"120","author":"Gupta","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib40","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1200\/JCO.2012.44.4729","article-title":"Growing importance of MYC\/BCL2 immunohistochemistry in diffuse large B-cell lymphomas","volume":"30","author":"Pfreundschuh","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.oooo.2014.06.002_bib41","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2014.06.002_bib42","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440314005240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440314005240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T01:10:41Z","timestamp":1597972241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440314005240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2212440314005240"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2014.06.002","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}